DD1

N/A

Report date: 2022/09/20 13:57:21
NME

Base Information

Drug NameDD1
Drug Alias NameDD-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImportin subunit beta-1 inhibitors
TargetsImportin subunit beta-1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A